Sernova (TSE:SVA) Stock Price Down 2.9% – Here’s Why

Sernova Corp. (TSE:SVAGet Free Report)’s stock price fell 2.9% during trading on Thursday . The company traded as low as C$0.17 and last traded at C$0.17. 135,769 shares changed hands during mid-day trading, a decline of 10% from the average session volume of 151,625 shares. The stock had previously closed at C$0.17.

Sernova Stock Performance

The stock has a market capitalization of C$55.52 million, a price-to-earnings ratio of -1.59 and a beta of 1.35. The company has a quick ratio of 18.11, a current ratio of 0.32 and a debt-to-equity ratio of -4.40. The stock’s 50-day simple moving average is C$0.19 and its 200 day simple moving average is C$0.20.

About Sernova

(Get Free Report)

Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem cells to create a bio-hybrid organ. A bio-hybrid organ refers to a medical device designed to be implanted into the human body, where it integrates with existing living tissue to replicate or enhance the function of a natural organ, essentially aiming to restore normal organ function by combining living cells with non-living materials to mimic the properties of the original organ and seamlessly interact with surrounding tissues.

See Also

Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.